URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

John Bisognano

Concepts (327)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Hypertension
34
1998
285
13.890
Why?
Antihypertensive Agents
21
1998
77
8.290
Why?
Baroreflex
9
2006
22
5.520
Why?
Electric Stimulation Therapy
9
2006
29
4.930
Why?
Blood Pressure
13
2004
446
3.920
Why?
Carotid Sinus
6
2006
11
2.390
Why?
Heart Failure
5
1996
337
1.740
Why?
Drug Resistance
6
2006
97
1.700
Why?
Humans
57
1993
35000
1.460
Why?
Diuretics
4
2006
33
1.440
Why?
Fumarates
3
2008
19
1.360
Why?
Amides
3
2008
35
1.350
Why?
Treatment Outcome
12
2004
2487
1.330
Why?
Angiotensin-Converting Enzyme Inhibitors
6
1998
48
1.330
Why?
Electrodes, Implanted
6
2006
53
1.240
Why?
Electrocardiography
5
2003
719
1.140
Why?
Renin-Angiotensin System
3
1999
18
1.130
Why?
Hospitalization
2
2007
354
0.970
Why?
Amlodipine
2
2004
6
0.970
Why?
Life Style
2
2011
80
0.920
Why?
Angiotensin Receptor Antagonists
2
1998
8
0.870
Why?
Female
22
1997
19061
0.830
Why?
Male
24
1997
18870
0.830
Why?
Emergency Treatment
2
1999
34
0.830
Why?
Tobacco Use Cessation Products
1
2012
3
0.830
Why?
Acute Coronary Syndrome
1
2012
7
0.820
Why?
Sympathetic Nervous System
2
2006
116
0.800
Why?
Heart Transplantation
2
1999
62
0.800
Why?
Middle Aged
17
1997
9461
0.800
Why?
Retrospective Studies
9
2004
2167
0.790
Why?
Renin
2
2008
58
0.790
Why?
Plant Preparations
1
2011
2
0.780
Why?
Patient Care
1
2012
34
0.780
Why?
Heart Neoplasms
2
2008
17
0.770
Why?
Implantable Neurostimulators
1
2011
2
0.760
Why?
Community Health Services
1
2012
68
0.760
Why?
Smoking Cessation
1
2012
77
0.750
Why?
Dietary Supplements
1
2011
43
0.750
Why?
Adrenergic beta-Antagonists
2
2007
152
0.750
Why?
Myocardial Ischemia
2
2007
112
0.740
Why?
Sympathectomy
1
2011
21
0.740
Why?
Lymphoma, Large B-Cell, Diffuse
2
2008
72
0.710
Why?
Arrhythmias, Cardiac
1
2012
224
0.700
Why?
Continuous Positive Airway Pressure
1
2010
6
0.700
Why?
Endocarditis
1
2010
10
0.690
Why?
Mitral Valve Insufficiency
1
2010
20
0.690
Why?
Hypertension, Pregnancy-Induced
1
2009
4
0.690
Why?
Sleep Apnea, Obstructive
1
2010
17
0.680
Why?
Mitral Valve
1
2010
35
0.680
Why?
Catheter Ablation
1
2011
72
0.680
Why?
Hemodynamics
2
2004
263
0.680
Why?
Thromboembolism
1
2010
37
0.680
Why?
Calcium Channel Blockers
2
2007
66
0.680
Why?
Quality of Health Care
1
2012
187
0.670
Why?
Pressoreceptors
1
2009
11
0.660
Why?
Erythema Multiforme
1
2009
3
0.650
Why?
Metoprolol
1
2009
10
0.650
Why?
Circadian Rhythm
1
2009
80
0.640
Why?
Music
1
2009
19
0.640
Why?
Aged
13
1998
6986
0.630
Why?
Staphylococcus aureus
1
2010
108
0.630
Why?
Comorbidity
3
2003
365
0.630
Why?
Diterpenes, Kaurane
1
2008
1
0.620
Why?
Pregnancy Outcome
1
2009
136
0.620
Why?
Sweetening Agents
1
2008
15
0.610
Why?
Smoking
1
2012
387
0.610
Why?
Deglutition Disorders
1
2008
20
0.600
Why?
Heart Diseases
1
2009
132
0.590
Why?
Echocardiography
5
1998
202
0.580
Why?
Trans Fatty Acids
1
2007
2
0.580
Why?
Drugs, Generic
1
2007
7
0.570
Why?
Kidney
1
2011
581
0.570
Why?
Natriuretic Peptide, Brain
1
2007
10
0.570
Why?
Blood Urea Nitrogen
1
2007
42
0.570
Why?
Cardiac Output, Low
1
2007
16
0.570
Why?
Energy Intake
1
2007
57
0.570
Why?
Vascular Diseases
1
2007
68
0.550
Why?
Patient Care Planning
1
2007
63
0.540
Why?
Protein Precursors
1
2007
82
0.540
Why?
Receptors, Endothelin
1
2006
15
0.530
Why?
Health Policy
1
2007
76
0.530
Why?
Coronary Disease
2
2003
247
0.530
Why?
Cardiovascular Diseases
2
2004
250
0.520
Why?
Ailanthus
1
2005
1
0.510
Why?
Leukoaraiosis
1
2005
1
0.510
Why?
Hospital Costs
1
2006
32
0.510
Why?
Myocarditis
1
2005
14
0.510
Why?
Geriatric Assessment
1
2007
158
0.510
Why?
Coronary Vasospasm
1
2005
8
0.500
Why?
Myocardium
3
1996
284
0.500
Why?
Peptide Fragments
1
2007
277
0.500
Why?
Tetrazoles
1
2004
9
0.490
Why?
Valine
1
2004
32
0.480
Why?
Brain Ischemia
1
2005
79
0.470
Why?
Follow-Up Studies
4
2003
1757
0.460
Why?
Emergency Service, Hospital
1
2006
187
0.450
Why?
Drug Therapy, Combination
4
1998
375
0.440
Why?
Stroke
1
2005
134
0.430
Why?
Myocardial Infarction
2
2003
630
0.430
Why?
Adult
11
1997
10906
0.430
Why?
Acute Disease
4
1999
570
0.420
Why?
Predictive Value of Tests
3
2008
579
0.420
Why?
Time Factors
4
2007
3047
0.420
Why?
New York
3
2007
1191
0.400
Why?
Aged, 80 and over
5
1998
2423
0.380
Why?
Prognosis
3
2007
1030
0.360
Why?
Receptors, Adrenergic, beta-1
1
2000
1
0.360
Why?
Randomized Controlled Trials as Topic
3
2004
400
0.350
Why?
Parvovirus B19, Human
1
1999
6
0.340
Why?
Parvoviridae Infections
1
1999
12
0.340
Why?
Animals
7
2000
15647
0.340
Why?
Europe
2
2007
74
0.330
Why?
Erythropoietin
1
1999
25
0.330
Why?
Proto-Oncogene Proteins c-bcl-2
1
2000
110
0.330
Why?
Hypertension, Malignant
1
1999
5
0.330
Why?
Stroke Volume
3
2007
140
0.320
Why?
Immunocompromised Host
1
1999
84
0.320
Why?
Heart
1
2000
228
0.320
Why?
Exercise
2
2008
155
0.310
Why?
Ventricular Outflow Obstruction
1
1998
11
0.310
Why?
Tricuspid Valve
1
1998
15
0.310
Why?
Risk Factors
3
2008
2172
0.300
Why?
Survival Rate
2
2007
584
0.300
Why?
Blood Pressure Monitoring, Ambulatory
2
2007
12
0.300
Why?
Subclavian Artery
1
1997
24
0.300
Why?
Odds Ratio
2
2003
301
0.290
Why?
Double-Blind Method
2
2008
985
0.280
Why?
United States
3
2007
2511
0.280
Why?
Biological Markers
3
2000
532
0.280
Why?
Logistic Models
2
2008
581
0.270
Why?
Michigan
2
2003
17
0.250
Why?
Erythrocytes
2
1993
341
0.250
Why?
Echocardiography, Transesophageal
2
1998
52
0.250
Why?
Length of Stay
2
2006
284
0.240
Why?
Angiotensin II Type 1 Receptor Blockers
2
2004
9
0.240
Why?
Clinical Trials as Topic
2
2007
664
0.240
Why?
Protons
2
1993
79
0.230
Why?
Hydroxides
1
1993
25
0.220
Why?
Labetalol
2
1999
4
0.220
Why?
Feasibility Studies
2
2004
189
0.210
Why?
Emergencies
2
1999
78
0.210
Why?
Electric Power Supplies
1
2012
10
0.200
Why?
Social Marketing
1
2012
7
0.200
Why?
Education
1
2012
35
0.200
Why?
Breathing Exercises
1
2011
3
0.200
Why?
Confidence Intervals
1
2012
155
0.200
Why?
Program Development
1
2012
73
0.190
Why?
Cohort Studies
2
2009
912
0.190
Why?
Cooperative Behavior
1
2012
95
0.190
Why?
Program Evaluation
1
2012
170
0.190
Why?
Registries
1
2012
203
0.180
Why?
Severity of Illness Index
2
1999
878
0.180
Why?
Practice Guidelines as Topic
2
2010
288
0.180
Why?
Ventricular Function, Left
1
2011
88
0.180
Why?
Motivation
1
2012
148
0.180
Why?
Nafcillin
1
2010
2
0.180
Why?
Rhinitis, Allergic, Perennial
1
2010
6
0.170
Why?
Retinal Vessels
1
2010
36
0.170
Why?
Echocardiography, Doppler, Color
1
2010
16
0.170
Why?
Eclampsia
1
2009
7
0.170
Why?
Maternal Mortality
1
2009
9
0.170
Why?
Blood Pressure Determination
1
2009
20
0.170
Why?
Incidence
1
2012
644
0.170
Why?
Health Promotion
1
2012
136
0.170
Why?
Carotid Body
1
2009
10
0.170
Why?
Meta-Analysis as Topic
1
2010
36
0.170
Why?
Pre-Eclampsia
1
2009
24
0.170
Why?
Hypersensitivity
1
2010
46
0.170
Why?
Markov Chains
1
2009
40
0.170
Why?
Diastole
1
2009
26
0.170
Why?
Monitoring, Physiologic
1
2009
94
0.160
Why?
Systole
1
2009
38
0.160
Why?
Prenatal Care
1
2009
65
0.160
Why?
Heart Atria
1
2009
62
0.160
Why?
Takotsubo Cardiomyopathy
1
2009
3
0.160
Why?
Hydroxyzine
1
2009
3
0.160
Why?
Adrenal Cortex Neoplasms
1
2009
12
0.160
Why?
Histamine H1 Antagonists
1
2009
15
0.160
Why?
Coronary Angiography
2
2005
78
0.160
Why?
Periodicity
1
2009
40
0.160
Why?
Pheochromocytoma
1
2009
38
0.160
Why?
Hypotension
1
2009
42
0.160
Why?
Treatment Failure
1
2009
125
0.160
Why?
Esophageal Neoplasms
1
2009
76
0.160
Why?
Drug Evaluation, Preclinical
1
2008
72
0.150
Why?
Chi-Square Distribution
1
2009
320
0.150
Why?
Equipment Design
1
2009
244
0.150
Why?
Proportional Hazards Models
1
2009
398
0.150
Why?
Carotid Arteries
1
2009
96
0.150
Why?
Kidney Diseases
1
2010
167
0.150
Why?
Posture
1
2008
107
0.150
Why?
Placebos
1
2008
177
0.150
Why?
Health Status Indicators
1
2008
97
0.150
Why?
Combined Modality Therapy
1
2009
459
0.140
Why?
Diet, Fat-Restricted
1
2007
3
0.140
Why?
Diet, Sodium-Restricted
1
2007
13
0.140
Why?
Minoxidil
1
2007
2
0.140
Why?
Body Weight
1
2008
328
0.140
Why?
Hospitals, Special
1
2007
7
0.140
Why?
Chlorthalidone
1
2007
4
0.140
Why?
Drug Costs
1
2007
22
0.140
Why?
Sodium Chloride Symporter Inhibitors
1
2007
10
0.140
Why?
Evidence-Based Medicine
1
2009
197
0.140
Why?
Electric Stimulation
1
2007
213
0.140
Why?
Risk Reduction Behavior
1
2007
36
0.140
Why?
Receptors, Cell Surface
1
2008
206
0.140
Why?
Patient Readmission
1
2007
39
0.140
Why?
Ambulatory Care Facilities
1
2007
28
0.140
Why?
Creatinine
1
2007
128
0.140
Why?
Video Games
1
2007
23
0.140
Why?
Diet
1
2008
196
0.140
Why?
Diabetes Complications
1
2007
60
0.140
Why?
Patient Admission
1
2007
77
0.140
Why?
Risk
1
2007
343
0.140
Why?
Asthma
1
2010
282
0.140
Why?
Multivariate Analysis
1
2008
487
0.130
Why?
Forecasting
1
2007
172
0.130
Why?
Obesity
1
2010
301
0.130
Why?
Captopril
1
2006
13
0.130
Why?
Metabolic Syndrome X
1
2007
56
0.130
Why?
Clonidine
1
2006
33
0.130
Why?
Vasoconstriction
1
2006
41
0.130
Why?
Heart Rate
1
2008
449
0.130
Why?
Patient-Centered Care
1
2007
71
0.130
Why?
Treatment Refusal
1
2006
37
0.130
Why?
Magnetic Resonance Imaging
2
2008
928
0.130
Why?
Anti-Bacterial Agents
1
2010
432
0.130
Why?
Patient Compliance
1
2007
170
0.130
Why?
Risk Assessment
1
2009
808
0.130
Why?
Nitroglycerin
1
2005
19
0.120
Why?
Nerve Fibers, Myelinated
1
2005
36
0.120
Why?
Young Adult
1
2009
1013
0.120
Why?
Disease Models, Animal
1
2009
908
0.120
Why?
Prevalence
1
2007
530
0.120
Why?
Isoproterenol
1
2004
74
0.120
Why?
Vasodilator Agents
1
2005
75
0.120
Why?
Adrenergic beta-Agonists
1
2004
52
0.120
Why?
Emergency Medical Services
1
2006
127
0.120
Why?
4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid
2
1993
12
0.120
Why?
Dementia
1
2005
91
0.120
Why?
Pregnancy
1
2009
1919
0.120
Why?
Graft Rejection
1
2005
142
0.120
Why?
Transplantation, Homologous
1
2005
261
0.110
Why?
Fatal Outcome
2
1997
101
0.110
Why?
Energy Metabolism
1
2004
132
0.110
Why?
Troponin I
1
2003
5
0.110
Why?
Chlorides
2
1993
122
0.110
Why?
Patient Education as Topic
1
2005
207
0.110
Why?
Creatine Kinase
1
2003
51
0.110
Why?
Cardiovascular Agents
1
2003
18
0.110
Why?
Cerebral Cortex
1
2005
235
0.110
Why?
Syndrome
1
2003
203
0.110
Why?
Sex Distribution
1
2003
142
0.110
Why?
Genetic Predisposition to Disease
1
2005
306
0.110
Why?
Age Distribution
1
2003
201
0.110
Why?
Disease Progression
1
2005
496
0.100
Why?
Reference Values
1
2003
427
0.100
Why?
Regression Analysis
1
2003
489
0.100
Why?
Rats
1
2009
4185
0.090
Why?
Diagnosis, Differential
2
1997
855
0.090
Why?
bcl-2-Associated X Protein
1
2000
52
0.090
Why?
Fenoldopam
1
1999
1
0.080
Why?
Adolescent
1
2008
4513
0.080
Why?
Nitroprusside
1
1999
32
0.080
Why?
Injections, Intravenous
1
1999
125
0.080
Why?
Drug Monitoring
1
1999
39
0.080
Why?
Infusions, Intravenous
1
1999
139
0.080
Why?
Aortitis
1
1997
1
0.080
Why?
Dyspnea
1
1997
12
0.080
Why?
Aortic Aneurysm, Thoracic
1
1997
16
0.070
Why?
Aneurysm, Infected
1
1997
10
0.070
Why?
Cough
1
1997
22
0.070
Why?
Proto-Oncogene Proteins
1
2000
261
0.070
Why?
Brain
1
2005
1161
0.070
Why?
Mice, Transgenic
1
2000
735
0.070
Why?
Gene Expression
1
2000
723
0.070
Why?
Streptococcus pyogenes
1
1997
102
0.070
Why?
Heterogeneous-Nuclear Ribonucleoprotein D
1
1996
2
0.070
Why?
Receptors, Adrenergic, beta
1
1996
64
0.060
Why?
Sodium
2
1993
296
0.060
Why?
Membrane Potentials
2
1993
338
0.060
Why?
Potassium
2
1993
303
0.060
Why?
Streptococcal Infections
1
1997
166
0.060
Why?
Chronic Disease
1
1997
496
0.060
Why?
Gramicidin
1
1994
2
0.060
Why?
Valinomycin
1
1994
15
0.060
Why?
Postoperative Complications
1
1999
706
0.060
Why?
RNA-Binding Proteins
1
1996
132
0.060
Why?
Apoptosis
1
2000
782
0.060
Why?
Ethoxzolamide
1
1993
2
0.060
Why?
4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid
1
1993
9
0.060
Why?
Carbocyanines
1
1993
20
0.060
Why?
Body Water
1
1993
33
0.060
Why?
Sucrose
1
1993
83
0.050
Why?
Saline Solution, Hypertonic
1
1993
28
0.050
Why?
Benzothiazoles
1
1993
54
0.050
Why?
Indicators and Reagents
1
1993
110
0.050
Why?
Osmolar Concentration
1
1993
153
0.050
Why?
Hemoglobins
1
1993
92
0.050
Why?
Scattering, Radiation
1
1993
74
0.050
Why?
Light
1
1993
151
0.050
Why?
Gene Expression Regulation
1
1996
848
0.040
Why?
Sleep Apnea Syndromes
1
2010
18
0.040
Why?
Esophagogastric Junction
1
2009
8
0.040
Why?
Hypertension, Pulmonary
1
2010
28
0.040
Why?
Endoscopy, Gastrointestinal
1
2009
24
0.040
Why?
Quality-Adjusted Life Years
1
2009
50
0.040
Why?
Sex Characteristics
1
2010
138
0.040
Why?
RNA, Messenger
1
1996
1791
0.040
Why?
Catecholamines
1
2009
76
0.040
Why?
Mice
1
2000
5900
0.040
Why?
Cost-Benefit Analysis
1
2009
200
0.040
Why?
Sensitivity and Specificity
1
2009
866
0.030
Why?
Tomography, X-Ray Computed
1
2009
729
0.030
Why?
Oxygen Consumption
1
2004
193
0.030
Why?
Polyribosomes
1
1996
21
0.020
Why?
Muscle, Smooth
1
1996
102
0.020
Why?
Ultraviolet Rays
1
1996
191
0.020
Why?
GTP-Binding Proteins
1
1996
136
0.020
Why?
DNA Primers
1
1996
401
0.020
Why?
Intracellular Fluid
1
1994
40
0.010
Why?
Cell Membrane Permeability
1
1994
100
0.010
Why?
Ion Transport
1
1994
69
0.010
Why?
Recombinant Proteins
1
1996
706
0.010
Why?
Base Sequence
1
1996
1681
0.010
Why?
Molecular Sequence Data
1
1996
1993
0.010
Why?
Signal Transduction
1
1996
1465
0.010
Why?

Visualizations


Bisognano's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department